SCHEMBL6963792

SCHEMBL6963792

CC(C)c1ccccc1Sc1c(O)cc(-c2cccc(Cl)c2)oc1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 5/20 0.43
GABRD O14764 5/20 0.43
GABRA1 P14867 5/20 0.43
GABRB1 P18505 5/20 0.43
GABRG2 P18507 5/20 0.43
GABRB3 P28472 5/20 0.43
GABRA5 P31644 5/20 0.43
GABRA3 P34903 5/20 0.43
GABRA2 P47869 5/20 0.43
GABRB2 P47870 5/20 0.43
GABRA4 P48169 5/20 0.43
GABRE P78334 5/20 0.43
GABRA6 Q16445 5/20 0.43
GABRG1 Q8N1C3 5/20 0.43
GABRG3 Q99928 5/20 0.43
GABRQ Q9UN88 5/20 0.43
PTPN1 P18031 1/20 0.40
PTGS2 P35354 1/20 0.40
CA12 O43570 2/20 0.38
CA9 Q16790 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6955040 0.91 CNR1 (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6954281 0.89 ALDH1A1 (0.42) CA12CA9CYP1A1CYP1A2CYP1B1
SCHEMBL6964481 0.89 TNKS (0.44) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6961039 0.88 SMN1; SMN2 (0.46) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6961237 0.88 QPCT (0.42) CA12CA9POLBSMN1; SMN2L3MBTL1
SCHEMBL6965601 0.87 NPSR1 (0.42) CYP1A2POLBSMN1; SMN2L3MBTL1NPSR1
SCHEMBL6958988 0.85 SMN1; SMN2 (0.41) CYP1A1CYP1A2CYP1B1POLBSMN1; SMN2
SCHEMBL6958727 0.84 CYP1A2 (0.42) CYP1A1CYP1A2CYP1B1SLC9A1KDM4E
SCHEMBL6963494 0.84 PTGES (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL6964073 0.83 AR (0.41) POLBSMN1; SMN2L3MBTL1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
US-5808062-A AIDS THERAPY WARNER-LAMBERT COMPANY (US) 1998-09-15 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed